Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4116 |  OABIW OmniAb, Inc. - Warrant | 0.3900 USD | 0.00% | 0.00% | +6.12% | +160.00% | 56.70 M USD | ||
| 4119 |  INKT MiNK Therapeutics, Inc. - Common Stock | 11.00 USD | -3.68% | -12.35% | -13.32% | 0.00% | 56.13 M USD | ||
| 4120 |  GUTS Fractyl Health, Inc. - Common Stock | 4.23 USD | -6.42% | +861.36% | +531.34% | +200.00% | 56.11 M USD | ||
| 4125 |  ATHE Alterity Therapeutics Limited - American Depositary Shares | 3.07 USD | -7.53% | -9.44% | -31.17% | -27.59% | 55.65 M USD | ||
| 4126 |  CNTB Connect Biopharma Holdings Limited - American Depositary Shares | 0.88 USD | -6.38% | -10.20% | -55.78% | -56.00% | 55.42 M USD | ||
| 4139 |  LONA LeonaBio, Inc. - Common Stock | 5.75 USD | -1.37% | +32.49% | -19.47% | -14.69% | 54.17 M USD | ||
| 4141 |  ACET Adicet Bio, Inc. - Common Stock | 5.74 USD | -7.12% | -14.33% | -39.32% | +523.91% | 53.73 M USD | ||
| 4151 |  HYPD Hyperion DeFi, Inc. - Common Stock | 3.37 USD | -6.13% | -12.69% | -4.80% | -62.47% | 52.37 M USD | ||
| 4155 |  DOMH Dominari Holdings Inc. - Common Stock | 2.15 USD | -0.46% | +2.38% | +11.40% | -65.82% | 52.12 M USD | ||
| 4156 |  XLO Xilio Therapeutics, Inc. - Common Stock | 9.01 USD | 0.00% | +1.35% | +0.67% | +947.67% | 52.10 M USD | ||
| 4161 |  CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 USD | -22.58% | -61.29% | -66.20% | -82.61% | 51.46 M USD | ||
| 4168 |  SER Serina Therapeutics, Inc. Common Stock | 2.00 USD | -0.99% | +0.50% | -20.00% | +19.76% | 50.80 M USD | ||
| 4169 |  INMB INmune Bio Inc. - Common stock | 1.83 USD | -1.61% | -5.67% | -24.69% | -7.58% | 50.79 M USD | ||
| 4172 |  ANVS Annovis Bio, Inc. Common Stock | 1.18 USD | -1.67% | -0.84% | -2.48% | -27.16% | 50.28 M USD | ||
| 4178 |  CRVO CervoMed Inc. - Common Stock | 3.28 USD | +3.14% | +10.81% | +31.20% | -61.82% | 49.59 M USD | ||
| 4194 |  APLM Apollomics Inc. - Class A Ordinary Shares | 21.70 USD | +0.93% | -7.66% | -9.21% | +17.93% | 47.65 M USD | ||
| 4196 |  ELTX Elicio Therapeutics, Inc. - Common Stock | 1.81 USD | -2.16% | -7.65% | -16.59% | -81.90% | 47.57 M USD | ||
| 4199 |  CELU Celularity Inc. - Class A Common Stock | 1.46 USD | -0.68% | +2.10% | +1.39% | -32.09% | 47.38 M USD | ||
| 4203 |  IMA ImageneBio, Inc. - Common Stock | 4.12 USD | -10.63% | -10.04% | -17.93% | -49.39% | 46.77 M USD | ||
| 4211 |  TVGN Tevogen Bio Holdings Inc. - Common Stock | 7.06 USD | +8.78% | +7.13% | -2.75% | +854.05% | 45.97 M USD |
Noticias Biotechnology Stocks
El fármaco de Pharvaris para el angioedema hereditario muestra alivio más rápido
Raymond James inicia cobertura de Kymera Therapeutics con Mejor Rendimiento
Raymond James inicia cobertura de Nektar con calificación de rendimiento de mercado
Palisade Bio inicia cobertura con Mejor Rendimiento según Raymond James
Raymond James reitera su calificación de Liquidia en medio de presentaciones legales
Tenax Therapeutics pausa temporalmente la inscripción en el ensayo LEVEL-2 de TNX-103 para modificar los criterios; solicita reunión con la FDA
Ginkgo Bioworks apoyará a los X-Labs de la NSF con acceso a su laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |